Search

Your search keyword '"MESH: Endosonography"' showing total 9 results
Start Over Descriptor "MESH: Endosonography"
9 results on '"MESH: Endosonography"'

1. Comparison of three-dimensional rectosonography, rectal endoscopic sonography and magnetic resonance imaging performances in the diagnosis of rectosigmoid endometriosis

Author

Charles-André Philip, Amélie Sandré, E. Maissiat, François Bailly, Gil Dubernard, Marion Cortet, Pierre De-Saint-Hilaire, Service de Gynécologie et Obstétrique [Hôpital de la Croix-Rousse - HCL], Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Service de Radiologie [Hôpital de la Croix-Rousse - HCL], and Service d'hépatogastroentérologie [Hôpital de la Croix-Rousse, Hospices Civils de Lyon]

Subjects
Endometriosis, MESH: Magnetic Resonance Imaging, Endosonography, Colonic Diseases, 0302 clinical medicine, Longitudinal Studies, 030212 general & internal medicine, MESH: Longitudinal Studies, Ultrasonography, MESH: Middle Aged, 030219 obstetrics & reproductive medicine, medicine.diagnostic_test, Obstetrics and Gynecology, Middle Aged, University hospital, Magnetic Resonance Imaging, MESH: Endometriosis, 3. Good health, medicine.anatomical_structure, MESH: Young Adult, Female, Segmental resection, MRI, Adult, Rectum, [SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics, Sensitivity and Specificity, Young Adult, 03 medical and health sciences, medicine, Humans, Retrospective Studies, Deeply infiltrating endometriosis, MESH: Endosonography, MESH: Humans, Pelvic endometriosis, business.industry, Significant difference, MESH: Adult, MESH: Retrospective Studies, Magnetic resonance imaging, Gold standard (test), MESH: Colonic Diseases, MESH: Rectal Diseases, medicine.disease, MESH: Sensitivity and Specificity, Rectal Diseases, Reproductive Medicine, Rectosigmoid endometriosis, Rectosonography, Rectal endoscopic sonography, Nuclear medicine, business, MESH: Female, MESH: Ultrasonography
Abstract

Study Objective Comparison of 3D-rectosonography (3D-RSG), rectal endoscopic sonography (RES), and MRI performances in the diagnosis of rectosigmoid endometriosis using surgery as the Gold Standard. Design Monocentric retrospective longitudinal study on diagnostic procedures. Design clasification Canadian Task Force II-2. Setting University Hospital of Lyon Croix-Rousse. Patients A total of 37 patients treated surgically for pelvic endometriosis. Interventions Expert 3D-RSG (3D Transvaginal sonography with water contrast in the rectum), MRI and RES performed by expert examiners. Sensitivity, specificity, accuracy, positive and negative predictive value, positive and negative likelihood ratios were calculated. Depth, size, and volume of intestinal lesions were also compared to the type of surgery performed (shaving versus segmental resection). Measurements and main results Rectosigmoid endometriosis lesion was confirmed by surgery in 31 patients on 37 (84%). Sensitivity, specificity, accuracy, positive and negative predictive value, positive and negative likelihood ratios for 3D-RSG were 94%, 100%, 95%, 100%, 75%, +∞ and 0.06 respectively; for RES 81%, 100%, 84%, 100%, 50%, +∞ and 0.19 respectively; while for MRI 90%, 100%, 92%, 100%, 67%, +∞ and 010 respectively. There was no significant difference between the 3 procedures (p > 0.05). Conclusion 3D-RSG, RES and MRI seem to be 3 effective procedures in the diagnosis of rectosigmoid endometriosis. Their performances seem equivalent.

Published
2019
Full Text
View/download PDF

2. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

Author

Diane Lorenzo, Frédérique Maire, Carmen Stefanescu, Jean-Marc Gornet, Philippe Seksik, Mélanie Serrero, Barbara Bournet, Philippe Marteau, Aurelien Amiot, David Laharie, Caroline Trang, Benoit Coffin, Guy Bellaiche, Guillaume Cadiot, Catherine Reenaers, Antoine Racine, Stephanie Viennot, Arnaud Pauwels, Guillaume Bouguen, Guillaume Savoye, Anne-Laure Pelletier, Guillaume Pineton de Chambrun, Pierre Lahmek, Stéphane Nahon, Vered Abitbol, Matthieu Allez, Marc Barthet, Laurent Beaugerie, Yoram Bouhnik, Arnaud Bourreille, Gaëlle Brillault, Louis Buscail, Franck Carbonnel, Stanislas Chaussade, Jacques Cosnes, Violette Delrieu, Patricia Détré, Jean-Charles Grimaud, Laure Jerber, Philippe Levy, Edouard Louis, Jacques Moreau, Thierry Paupard, Vinciane Rebours, Philippe Ruszniewski, Mélanie Sererro, Marion Simon, Harry Sokol, Gilles Tordjman, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Beaujon, Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Hôpital Saint-Louis, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Nord [CHU - APHM], Hôpital de Rangueil, CHU Toulouse [Toulouse], Service d'hépato-gastro-entérologie [APHP Henri Mondor], Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Hôpital Henri Mondor-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Centre hospitalier universitaire de Nantes (CHU Nantes), Hôpital Louis Mourier - AP-HP [Colombes], Hôpital Robert Ballanger [Aulnay-sous-Bois], Centre Hospitalier Universitaire de Reims (CHU Reims), Centre Hospitalier Universitaire de Liège (CHU-Liège), Hôpital Bicêtre, Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, Service d'Hépato-Gastro-Enterologie et Nutrition [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier de Gonesse, CHU Pontchaillou [Rennes], Service d'Hépato-Gastroentérologie [CHU Rouen], Hôpital Charles Nicolle [Rouen]-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU), Nutrition, inflammation et dysfonctionnement de l'axe intestin-cerveau (ADEN), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute for Research and Innovation in Biomedicine (IRIB), Normandie Université (NU)-Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), UNIROUEN - UFR Santé (UNIROUEN UFR Santé), Normandie Université (NU)-Normandie Université (NU), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Groupe d’Étude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID), CHU Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7), CHU Saint-Antoine [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hopital Louis Mourier - AP-HP [Colombes], Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Bicêtre, Service d'Hépato-Gastroentérologie [Rouen], Normandie Université (NU)-Normandie Université (NU)-Hôpital Charles Nicolle [Rouen]-CHU Rouen, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), and Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

Subjects
MESH: Histocytochemistry, Male, medicine.medical_treatment, Long-term Outcome, Biopsy, Gastroenterology, Inflammatory bowel disease, GETAID Study, Endosonography, MESH: Biopsy, 0302 clinical medicine, MESH: Belgium, Belgium, MESH: Autoimmune Diseases, Colectomy, MESH: Treatment Outcome, Crohn's disease, MESH: Middle Aged, Histocytochemistry, Middle Aged, Ulcerative colitis, MESH: Case-Control Studies, 3. Good health, MESH: Pancreatitis, Treatment Outcome, MESH: Young Adult, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Female, France, Adult, medicine.medical_specialty, [SDV.CAN]Life Sciences [q-bio]/Cancer, Autoimmune Diseases, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, Exocrine pancreatic insufficiency, Pancreas, Proctitis, Autoimmune pancreatitis, Retrospective Studies, MESH: Endosonography, MESH: Humans, Hepatology, business.industry, Case-control study, MESH: Adult, MESH: Retrospective Studies, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, medicine.disease, MESH: Inflammatory Bowel Diseases, Inflammatory Bowel Diseases, MESH: Male, MESH: France, Pancreatitis, Case-Control Studies, Surgery, business, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience; BACKGROUND & AIMS:Few people know of autoimmune pancreatitis (AIP), a rare disorder associated with inflammatory bowel diseases (IBD). We aimed to describe phenotype and outcomes of IBD and AIP when associated.METHODS:We performed a retrospective study of cases of AIP in IBD identified from the multicenter Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif in Belgium and France from July 2012 through July 2015. Patients were diagnosed with AIP based on the International Consensus Diagnostic Criteria for AIP. A definitive AIP diagnosis was based on histological analysis of pancreatic resection specimens or samples collected by fine-needle aspiration during endoscopic ultrasound. Patients with probable type 1 AIP were identified based on imaging findings, clinical and/or radiologic responses to steroids, level of serum immunoglobulin G4, and involvement of other organs. Patients with probable type 2 AIP were identified based on imaging findings, clinical and/or radiologic responses to steroids, and association with IBD. The primary objective was to collect information on the characteristics of AIP in patients with IBD. We also compared features of patients with IBD with and without AIP in a case-control analysis, using multivariate analysis.RESULTS:We analyzed data from 91 individuals with AIP and IBD (47 women) seen at 23 centers (58 had ulcerative colitis [UC] and 33 Crohn's disease [CD]). Eighty-nine patients had type 2 AIP, and 2 patients had type 1 AIP. The mean age at diagnosis of AIP was 35 ± 12 years, and for IBD it was 32 ± 12 years. AIP preceded IBD in 19 patients (21%). Over a mean follow-up period of 5.7 ± 4.9 years, 31 patients (34%) relapsed, 11 patients (12%) developed diabetes, and 17 patients (19%) developed exocrine pancreatic insufficiency. In patients with UC, factors independently associated with AIP included proctitis (odds ratio [OR], 2.9; 95% confidence interval [CI], 1.3-6.3; P = .007) and colectomy (OR, 7.1; 95% CI, 2.5-20; P = .0003). In patients with CD, AIP was significantly associated with fewer perianal lesions (OR, 0.16; 95% CI, 0.03-0.77; P = .023), non-stricturing non-penetrating CD (OR, 6.7; 95% CI, 1.25-33.3; P = .0029), and higher rate of colectomy (OR, 27.8; 95% CI, 3.6-217; P = .0029).CONCLUSIONS:In a multicenter retrospective analysis of patients with AIP and IBD, followed for an average of 5.7 ± 4.9 years, we found most to have type 2 AIP. Two-thirds of patients have UC, often with proctitis. One-third of patients have CD, often with inflammatory features. Patients with IBD and AIP have higher rates of colectomy than patients with just IBD.

Published
2017
Full Text
View/download PDF

3. Contrast-Enhanced Ultrasound and Prostate Cancer; A Multicentre European Research Coordination Project

Author

Michael Mitterberger, Ferdinand Frauscher, Chris J Harvey, Margot H. Wink, Olivier Rouvière, Leo Palwein, Jean J.M.C.H. de la Rosette, Jean-Yves Chapelon, Hessel Wijkstra, David O. Cosgrove, Inst Pharm & Mol Biotechnol, Universität Heidelberg [Heidelberg], Applications des ultrasons à la thérapie, Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'étude spatiale des rayonnements (CESR), Observatoire Midi-Pyrénées (OMP), Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Centre National de la Recherche Scientifique (CNRS)-Institut national des sciences de l'Univers (INSU - CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées, Signal Processing Systems, and Biomedical Diagnostics Lab

Subjects
Male, medicine.medical_specialty, Biopsy, Urology, 030232 urology & nephrology, Contrast Media, Context (language use), SDG 3 – Goede gezondheid en welzijn, Endosonography, MESH: Biopsy, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Prostate, MESH: Contrast Media, medicine, Humans, Neoplasm Staging, MESH: Endosonography, MESH: Humans, business.industry, Ultrasound, Prostatic Neoplasms, Reproducibility of Results, Cancer, Ultrasonography, Doppler, MESH: Neoplasm Staging, medicine.disease, MESH: Male, 3. Good health, Surgery, MESH: Reproducibility of Results, Europe, medicine.anatomical_structure, MESH: Prostatic Neoplasms, 030220 oncology & carcinogenesis, MESH: Ultrasonography, Doppler, Microbubbles, Hormonal therapy, [SDV.IB]Life Sciences [q-bio]/Bioengineering, MESH: Europe, Radiology, business, Contrast-enhanced ultrasound
Abstract

Context: Contrast-enhanced ultrasound is a real-time imaging technique with the capability of visualizing perfusion patterns. Since tumour growth is associated with changes in vascularisation, this modality is under research for imaging of various tumour types. Studies have shown promising results for the diagnosis of prostate cancer for various imaging techniques; however, the exact value of each technique is still unclear. Objective: To determine the value of contrast-enhanced ultrasound (CEUS) in the detection, localisation, and follow-up of treatment for prostate cancer. Evidence acquisition: In the period 2002-2006, research in four European centres regarding CEUS of the prostate was coordinated in a combined program. This paper describes and combines the results of these studies. Evidence synthesis: Various techniques were developed and researched during the period of this program. Studies showed that prostate cancer could be visualized and localized in up to 78%. Visualization of the tumour enabled better detection; targeted biopsies lead to fewer biopsies per session without loss of detection rate. A combined approach offered the highest detection rate. CEUS could be used to visualize the effects of high-intensity focussed ultrasound and hormonal therapy for prostate cancer with success, and identified patients with an early relapse. Unfortunately, pretreatment evaluation could not identify the nonresponders beforehand. Conclusions: This research project was a first step towards routine use of CEUS in the clinical detection and follow-up of prostate cancer; and new combined studies are initiated. (C) 2008 European Association of Urology. Published by Elsevier B.V. All rights reserved

Published
2008
Full Text
View/download PDF

4. Management of gastrointestinal stromal tumours of limited size: proposals from a French panel of physicians

Author

Bruno Landi, Marc Giovannini, Rosine Guimbaud, Bertrand Napoleon, Olivier Bouché, Anne Berger, Laurent Palazzo, Sylvie Bonvalot, Christian Boustière, Geneviève Monges, Jean-François Emile, Axel Le Cesne, Thomas Aparicio, Jean-Yves Blay, Bruno Buecher, Coindre Jm, Thierry Lecomte, Jean-Alain Chayvialle, Hôpital Européen Georges Pompidou [APHP] ( HEGP ), Hôpital Robert Debré, Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims ( CHU Reims ), Département d'oncologie médicale, Institut Claudius Regaud, Service de Gastro-entérologie [Avicenne], Université Paris 13 ( UP13 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Avicenne, Assistance Publique-Hopitaux de Paris, Centre d'Investigation Clinique en Biotherapie des cancers ( CIC 1428 , CBT 507 ), Institut Gustave Roussy ( IGR ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Service de Génétique Oncologique, INSTITUT CURIE, Equipe 11, Centre de Recherche en Cancérologie de Lyon ( CRCL ), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Service d'Oncologie Médicale, Centre Léon Bérard [Lyon], Laboratoire épidémiologie et oncogénèse des tumeurs digestives, Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ), Department of Endoscopy, Université de la Méditerranée - Aix-Marseille 2, Génétique, Immunothérapie, Chimie et Cancer ( GICC ), Université de Tours-Centre National de la Recherche Scientifique ( CNRS ), Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy ( IGR ), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), hopital jean mermoz, Departement de Gastroenterologie, Clinique Turin, Departement d' endoscopie, Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon ( HCL ), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims), Université Paris 13 (UP13)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre d'Investigation Clinique en Biotherapie des cancers (CIC 1428 , CBT 507 ), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Curie [Paris], Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Service d'Oncologie Médicale, Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Génétique, immunothérapie, chimie et cancer (GICC), UMR 6239 CNRS [2008-2011] (GICC UMR 6239 CNRS), Université de Tours-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), Hospices Civils de Lyon (HCL), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris 13 (UP13)-Hôpital Avicenne [AP-HP], Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Service d'Oncologie Médicale, Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), and Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

Subjects
MESH : Watchful Waiting, MESH : Laparoscopy, Biopsy, MESH: Laparoscopy, MESH: Ultrasonography, Interventional, MESH : Ultrasonography, Interventional, Gastroenterology, MESH : Consensus, MESH : Tomography, Spiral Computed, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, Endosonography, MESH: Biopsy, MESH: Gastrointestinal Neoplasms, 0302 clinical medicine, MESH: Practice Guidelines as Topic, Surveys and Questionnaires, Gastrointestinal Neoplasms, GiST, medicine.diagnostic_test, MESH : Gastrointestinal Stromal Tumors, MESH : Questionnaires, Gastrointestinal stromal tumours, 3. Good health, MESH: Watchful Waiting, MESH : Practice Guidelines as Topic, 030220 oncology & carcinogenesis, MESH : Endosonography, Practice Guidelines as Topic, 030211 gastroenterology & hepatology, France, MESH: Gastrointestinal Stromal Tumors, medicine.medical_specialty, Consensus, Gastrointestinal Stromal Tumors, Stromal tumours, MESH : Gastrointestinal Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Endoscopic ultrasonography, 03 medical and health sciences, Internal medicine, medicine, Humans, MESH: Consensus, MESH : France, Watchful Waiting, Ultrasonography, Interventional, MESH: Endosonography, MESH: Humans, Hepatology, business.industry, General surgery, MESH: Questionnaires, MESH : Humans, Expert consensus, Endoscopy, MESH: France, MESH : Biopsy, Laparoscopy, MESH: Tomography, Spiral Computed, business, Tomography, Spiral Computed
Abstract

International audience; A number of guidelines on the management of gastro-intestinal stromal tumours (GISTs) have been published, mostly based on expert consensus. However, these guidelines have generally failed to address the specific problem of GISTs of limited size (i.e. those measuring a few centimetres in diameter) with which gastroenterologists are increasingly confronted. The aim of the present work was to draw up proposals for the diagnosis and treatment of GISTs measuring less than 5 cm in diameter. For this purpose, a number of practical questions were put to a panel of French experts.

Published
2010
Full Text
View/download PDF

5. Peroral transgastric/transduodenal necrosectomy: success in the treatment of infected pancreatic necrosis

Author

Gilles Fourtanier, Pierre Andrau, Jean Escourrou, Hany Shehab, Louis Buscail, Barbara Bournet, Jacques Moreau, Pôle Maladies de l'appareil digestif [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Chirurgie Générale et Digestive [Rangueil], and Simon, Marie Francoise

Subjects
Male, Necrosis, medicine.medical_treatment, MESH: Pancreatitis, Acute Necrotizing, MESH: Retroperitoneal Space, Endosonography, Digestive System Surgical Procedures, MESH: Treatment Outcome, MESH: Digestive System Surgical Procedures, MESH: Aged, MESH: Middle Aged, medicine.diagnostic_test, Pancreatitis, Acute Necrotizing, Middle Aged, Treatment Outcome, medicine.anatomical_structure, Female, medicine.symptom, Pancreas, MESH: Tomography, X-Ray Computed, Adult, Reoperation, medicine.medical_specialty, MESH: Reoperation, Disease-Free Survival, MESH: Endoscopy, medicine, Humans, Retroperitoneal space, Retroperitoneal Space, Transduodenal approach, MESH: Debridement, Aged, MESH: Necrosis, Debridement, MESH: Endosonography, MESH: Humans, business.industry, Endoscopy, MESH: Adult, Infected pancreatic necrosis, medicine.disease, MESH: Male, Surgery, MESH: Disease-Free Survival, Pancreatitis, Tomography, X-Ray Computed, business, MESH: Female
Abstract

International audience; OBJECTIVE: To assess the results and complications of an endoscopic transgastric/transduodenal approach as a possible alternative to conventional surgery. SUMMARY BACKGROUND DATA: Infected organized pancreatic necrosis carries a high mortality despite antibiotic therapy and numerous conventional and laparoscopic surgical techniques of debridement. The advent of natural orifice transluminal endoscopic surgery (NOTES) provides a possible alternative approach. METHODS: Between 2004 and 2007, patients with infected organized pancreatic necrosis were referred for endoscopic necrosectomy as their initial treatment of choice. Accessibility was confirmed by CT and endoscopic ultrasound. Access to the cavities was transgastric or transduodenal, after passing the endoscope inside the retroperitoneal cavity all necrotic and purulent material was evacuated under direct endoscopic vision. RESULTS: Thirteen patients (12 men, mean age: 55 years, range: 38-66 years) underwent endoscopic necrosectomy. Two patients had complementary percutaneous drainage for endoscopically inaccessible cavities. Resolution infection was the rule in all cases. Infection recurred in 4 patients and a necrotic cavity persisted in 1 patient; all were managed by further endoscopic necrosectomies (total = 23 necrosectomy sessions; mean, 1.8 per patient; range, 1-3). Mean duration of each session was 3.5 hours (range, 2.5-4 hours). Endoscopic treatment was eventually successful in all patients with gradual diminution of the necrotic cavities on CT images. Average duration of follow-up was 19.5 months (range, 2-56 months) with no recurrence of the infectious process and no surgery was required for any patient. Complications included bleeding (n = 3) and transient aggravation of sepsis (n = 3). No mortality occurred. CONCLUSIONS: This technique is highly effective and safe in the treatment of infected organized pancreatic necrosis. Results are achievable and sustainable with a limited number of sessions.

Published
2008
Full Text
View/download PDF

6. Radiologic evaluation of pelvic floor disorders

Author

C. Savoye-Collet, Edith Koning, Jean-Nicolas Dacher, Service d'imagerie médicale [CHU Rouen], Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU), Breton, Céline, Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, and Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN)

Subjects
medicine.medical_specialty, MESH: Defecography, MESH: Pelvic Pain, Pelvic Pain, 030218 nuclear medicine & medical imaging, Pelvic Floor Disorders, Endosonography, MESH: Magnetic Resonance Imaging, 03 medical and health sciences, 0302 clinical medicine, Radiologic Evaluation, medicine, Defecography, Humans, Pelvic floor, MESH: Endosonography, MESH: Humans, medicine.diagnostic_test, business.industry, Gastroenterology, Imaging Procedures, Magnetic resonance imaging, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Pelvic Floor, MESH: Rectal Diseases, Magnetic Resonance Imaging, [SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, 3. Good health, Perineum, body regions, medicine.anatomical_structure, Rectal Diseases, Urinary Incontinence, MESH: Pelvic Floor, 030211 gastroenterology & hepatology, Radiology, Tomography, business, Tomography, X-Ray Computed, MESH: Tomography, X-Ray Computed, MESH: Urinary Incontinence
Abstract

International audience; Several imaging modalities are available ranging from fluoroscopic techniques to ultrasonography and MRI for the evaluation of patients with pelvic floors disorders. High-resolution ultrasonography and MRI not only provide superior delineation of the pelvic floor anatomy but also reveal pathology and functional changes. This article focuses on standard imaging procedures including defecography, ultrasonography, and MRI and discusses its use in clinical practice by illustrating both normal and abnormal patterns.

Published
2008
Full Text
View/download PDF

7. [Endoscopic management of postoperative pancreatic collections]

Author

Subtil, C., Moutardier, V., Vitton, V., Gasmi, M., Desjeux, A., Grimaud, J.-C., Berdah, S., Barthet, M., C, Brunet, Centre de recherche en neurobiologie - neurophysiologie de Marseille (CRN2M), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Image et ville (IV), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche et d'Application en Traitement de l'Image et du Signal (CREATIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-École Supérieure de Chimie Physique Électronique de Lyon (CPE)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-École Supérieure Chimie Physique Électronique de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), and Dumonceaud, Corinne

Subjects
Adult, Male, Adenocarcinoma, MESH: Splenectomy, MESH: Exudates and Transudates, MESH: Drainage, Endosonography, MESH: Pancreatic Cyst, Pancreatectomy, Postoperative Complications, MESH: Endoscopy, Digestive System, MESH: Pancreatectomy, MESH: Postoperative Complications, Cystadenoma, Mucinous, Pancreatic Pseudocyst, Humans, Endoscopy, Digestive System, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM], [SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM], MESH: Pancreatic Pseudocyst, Aged, MESH: Aged, Cholangiopancreatography, Endoscopic Retrograde, MESH: Humans, MESH: Middle Aged, MESH: Endosonography, MESH: Adenocarcinoma, MESH: Adult, Exudates and Transudates, Middle Aged, MESH: Male, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM], MESH: Cystadenoma, Mucinous, Pancreatic Neoplasms, Splenectomy, Drainage, MESH: Cholangiopancreatography, Endoscopic Retrograde, Female, MESH: Pancreatic Neoplasms, Pancreatic Cyst, MESH: Tomography, X-Ray Computed, Tomography, X-Ray Computed, MESH: Female
Abstract

International audience; INTRODUCTION: Treatment of pancreatic postoperative collections are usually managed with a multidisciplinary team. Different managements are possible: abstention, external drainage, endoscopic treatment or surgery. METHODS: We report on a case series of five patients with a postoperative pancreatic collection, endoscopically managed. Patients underwent all a CT scan associated or not with endoscopic ultrasonography. RESULTS: An endoscopic cystenterosotomy was performed in all the cases, with two double pig tail stents sometimes associated with nasocystic drainage for clearing the cyst lumen and with transpapillary drainage in one case. All the procedures were successful and patients healed in all the cases with the disappearance of the radiological image within a 33 days to three months range with one complication due to superinfection of the drained cyst, endoscopically managed with a nasocystic catheter. CONCLUSION: Therapeutic endoscopy, with a multidisciplinary approach, is a promising way to manage postoperative pancreatic collections.

Published
2008

8. [Ultrasound interstitial mini invasive probes for thermal ablation in liver: feasibility study in vivo]

Author

E, Delabrousse, F, Mithieux, A, Birer, R, Salomir, Jy, Chapelon, C, Lafon, Applications des ultrasons à la thérapie, Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
MESH: Endosonography, Swine, Ultrasonic Therapy, Transducers, MESH: Ultrasonography, Interventional, MESH: Electrocoagulation, MESH: Ultrasonic Therapy, Endosonography, Liver, MESH: Models, Animal, Models, Animal, Electrocoagulation, Animals, Feasibility Studies, MESH: Animals, [SDV.IB]Life Sciences [q-bio]/Bioengineering, MESH: Feasibility Studies, MESH: Swine, Ultrasonography, Interventional, MESH: Liver, MESH: Transducers
Abstract

International audience; High intensity ultrasounds are routinely used for thermal ablation of some cancers. However, for treating hepatic tumours with physical agents, RF applicators and cryoprobes are still preferred. The goal of the present study was to demonstrate the feasibility of using interstitial ultrasound probes in liver following two approaches: percutaneous and intra-tissular or endo vascular. In vivo trials on a porcine model demonstrated the minimally invasive nature of both procedures. Homogeneous and reproducible thermal lesions, up to 20 mm deep, were obtained. The work on these two original approaches deserves to be completed with more extended prospective studies. The association with an imaging method will have to be studied before proceeding to clinical trials.

Published
2007

9. Clinical usefulness of a treatment algorithm for pancreatic pseudocysts

Author

Marc Barthet, Gatien Lamblin, Ariadne Desjeux, Véronique Vitton, Jean-Charles Grimaud, Mohamed Gasmi, Image et ville (IV), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Centre de recherche en neurobiologie - neurophysiologie de Marseille (CRN2M), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche et d'Application en Traitement de l'Image et du Signal (CREATIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-École Supérieure Chimie Physique Électronique de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Lyon-Université de Lyon-École Supérieure de Chimie Physique Électronique de Lyon (CPE)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), and Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

Subjects
Male, Pancreatic disease, Endoscopy, Gastrointestinal, Endosonography, Cohort Studies, 0302 clinical medicine, MESH: Child, Prospective Studies, Prospective cohort study, Child, MESH: Pancreatic Pseudocyst, MESH: Aged, MESH: Middle Aged, medicine.diagnostic_test, Mortality rate, Gastroenterology, Middle Aged, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM], 3. Good health, MESH: Endoscopy, Gastrointestinal, MESH: Pancreatitis, medicine.anatomical_structure, Treatment Outcome, 030220 oncology & carcinogenesis, Child, Preschool, Portal hypertension, Drainage, 030211 gastroenterology & hepatology, Female, Radiology, MESH: Tomography, X-Ray Computed, Algorithm, Algorithms, Adult, medicine.medical_specialty, Pancreatic pseudocyst, Adolescent, MESH: Algorithms, Risk Assessment, MESH: Drainage, 03 medical and health sciences, Hypertension, Portal, Pancreatic Pseudocyst, medicine, Humans, Radiology, Nuclear Medicine and imaging, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM], Aged, Pancreatic duct, MESH: Adolescent, MESH: Hypertension, Portal, MESH: Humans, MESH: Endosonography, business.industry, MESH: Child, Preschool, MESH: Adult, medicine.disease, digestive system diseases, MESH: Male, MESH: Prospective Studies, Surgery, Endoscopy, Pancreatitis, business, Tomography, X-Ray Computed, MESH: Female, Follow-Up Studies
Abstract

International audience; BACKGROUND: Endoscopic procedures have become a first-line approach to the treatment of pancreatic pseudocysts. OBJECTIVE: Our purpose was to determine the results of a therapeutic algorithm including EUS-assisted drainage, transpapillary drainage, and conventional endoscopic drainage in terms of (1) feasibility and efficacy of the endoscopic procedure and (2) morbidity. DESIGN: Prospective study with a treatment algorithm drawn up before the endoscopic procedure, including either conventional endoscopic transmural drainage (CTMD), conventional transpapillary drainage (CTPD), or EUS-guided transmural drainage (EUS-GTD). PATIENTS: A total of 50 patients, including 15 women and 35 men with a mean age of 51 years, were included in this prospective study. RESULTS: The mean size of the pseudocysts was 8.2 cm (range 3-12 cm). A total of 29 pseudocysts did not bulge into the digestive wall (58%); 24 (48%) neither bulged nor communicated with the pancreatic duct. EUS-GTD was performed on 28 patients (56%), CTMD on 13 patients (26%), and CTPD on 8 patients (16%), and endoscopic procedures failed in 1 patient. Technical feasibility was 98% (49/50), and clinical success was achieved in 90% of the cases and disappearance of the pseudocysts in 96% of the cases without significant differences among the 3 groups. The morbidity rate was 18% (9 cases). Five superinfections occurred in the EUS-GTD group and 1 in the CTMD group. One death occurred from late bleeding in the CTMD group. LIMITATION: Randomization of patients in this prospective study was not possible because of the different characteristics of the pseudocysts. CONCLUSION: With this algorithm, clinical success was achieved in 45 (90%) of the cases and disappearance of the pseudocysts in 48 (96%) of the cases with a reasonable morbidity rate. In half of the cases, EUS is required for treating pancreatic pseudocyst.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results